Evidence map›Paper›PMID 17674158›Full record

ReviewPharmaceutical research2008

The apoptosome: emerging insights and new potential targets for drug design.

Marcello D'Amelio, Elisa Tino, Francesco Cecconi

Open access · hybridAbstract readReview
In one paragraph

Review in Pharmaceutical research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Targeting apoptosis in autoimmune hepatitis.Digestive diseases and sciences · 2014
    Review
  8. Development of anticancer drugs based on the hallmarks of tumor cells.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Review
  9. BCNU/PLGA microspheres: a promising strategy for the treatment of gliomas in mice.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2014
    Article
  10. LncRNAs: New Players in Apoptosis Control.International journal of cell biology · 2014
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Marcello D'AmelioLaboratory of Molecular Neuroembryology, IRCCS Fondazione Santa Lucia, 00143, Rome, Italy.
Elisa Tino
Francesco Cecconi
University of Rome Tor Vergata · IT

Funding

Telethon TCR04004
6 · The paper itself

Abstract

Apoptosis plays a crucial role in tissue homeostasis, development and many diseases. The relevance of Apaf1, the molecular core of apoptosome, has been underlined in mitochondria-dependent apoptosis, which according to a growing body of evidence, is involved in various pathologies where the equilibrium of life-and-death is dysregulated, such as heart attack, stroke, liver failure, cancer and autoimmune diseases. Consequently, great interest has emerged in devising therapeutic strategies for regulating the key molecules involved in the life-and-death decision. Here we review recent progress in apoptosis-based pharmacological therapies and, in particular, we point out a possible role of the apoptosome as an emerging and promising pharmacological target.

Indexed as

Drug DesignAnimalsApoptosisApoptosomesCaspasesDrug Evaluation, PreclinicalHumansProto-Oncogene Proteins c-bcl-2Signal TransductionApoptosomesCaspasesProto-Oncogene Proteins c-bcl-2

Identifiers

PMID17674158
PMCPMC2279152
OpenAlexW2005131979

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.